Clinical Trial Update: Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a conditioning regimen of cyclophosphamide and anti-thymocyte globulin followed by methotrexate and cyclosporine to prevent chronic gra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Graft-versus-host Disease

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYCLOSPORINE (cyclosporine)
• METHOTREXATE (METHOTREXATE)
• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2017-03-16